The Pharmacological Effects of Using Cabozantinib With a Light Breakfast

NCT05263245 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

OTHER: Light breakfast

Sponsor

dr. Tom van der Hulle

Collaborators

[object Object]